Nuvectis Pharma, Inc. (NVCT) closed the last trading session at $8.15, gaining 34.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22 indicates a 169.9% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $2.65. While the lowest estimate of $20 indicates a 145.4% increase from the current price level, the most optimistic analy ...